Teva received FDA approval for their first and only digital inhaler, ProAir Digihaler, for treatment of bronchospasm.

03 January 2019 Written by CN1699 Services Article viewed 5 times (1 times in the last week)

The ProAir Digihaler usesdata sent to the companion mobile app so patients can review the results and share it to medical professionals.

For more product details and uses visit ProAirdigihaler.

Image from ProAirdigihaler

Karen C

Off-Shore Manager - CN1699 Services